IND ENABLING DEVELOPMENT OF CF-296, A LYSIN FOR THE TREATMENT OF INVASIVE STAPHYLOCOCCUS AUREUS (S. AUREUS) INFECTIONS

$5,203,776FY2019Defense Health AgencyDOD

Contrafect Corporation

Investigators